Mosaicism in sporadic neurofibromatosis 2 patients
Authors:
Open Access
- 1 December 1998
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 7 (13) , 2051-2055
Abstract
More than half of neurofibromatosis 2 (NF2) patients represent de novo mutations which could have occurred at either pre-zygotic or post-zygotic stages. A post-zygotic mutation can result in mosaicism. In four sporadic NF2 patients, we found NF2 mutations in only a portion of corresponding leukocytes. In two other sporadic patients, no mutations were found in leukocytes but constitutional NF2 mutations were suggested by identical mutations in different tumors from each patient. We screened leukocyte DNA from a total of 16 inherited and 91 sporadic NF2 patients, and found NF2 mutations in 13 (81%) of the former and in 46 (51%) of the latter cases. The 30% difference in the rate of detection of mutations (P= 0.051) might be partially explained by mosaicism in a portion of sporadic NF2 patients who carry the mutations in such a fashion that their leukocytes are unaffected. Among sporadic cases, we found mutations more frequently in patients with severe phenotypes (59%) than in patients with mild phenotypes (23%) (difference of 36%, P = 0.007). Mosaicism might be more common in the latter patient group since small populations of mutation-bearing cells can in some cases result in mild phenotypes and can also lead to difficulties in identifying mutations. No mutations were found in eight patients suspected of having NF2. Mosaicism with an extremely small population of affected cells may explain the incomplete phenotypes in some of these patients and the lack of mutations in their leukocytes. These findings suggest that mosaicism is relatively common in NF2 and may have important implications for diagnosis, prognosis and genetic counseling.Keywords
This publication has 18 references indexed in Scilit:
- The Diagnostic Evaluation and Multidisciplinary Management of Neurofibromatosis 1 and Neurofibromatosis 2JAMA, 1997
- Somatic mosaicism for deletion of the entire NF1 gene identified by FISHHuman Genetics, 1997
- Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypesHuman Genetics, 1996
- Frequency and distribution ofNF2 mutations in schwannomasGenes, Chromosomes and Cancer, 1996
- A 163-bp deletion at the C-terminus of the schwannomin gene associated with variable phenotypes of neurofibromatosis type 2Human Genetics, 1995
- Screening for germ‐line mutations in the NF2 GeneGenes, Chromosomes and Cancer, 1995
- Neurofibromatosis Type 1 Due to Germ-Line Mosaicism in a Clinically Normal FatherNew England Journal of Medicine, 1994
- Neurofibromatosis 2 (NF2): Clinical characteristics of 63 affected individuals and clinical evidence for heterogeneityAmerican Journal of Medical Genetics, 1994
- Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomasNature Genetics, 1994
- Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2Nature, 1993